Literature DB >> 25636800

Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation.

Siqi Liu1, Xin Cai1, Jiaxi Wu1, Qian Cong2, Xiang Chen3, Tuo Li1, Fenghe Du3, Junyao Ren1, You-Tong Wu1, Nick V Grishin4, Zhijian J Chen5.   

Abstract

During virus infection, the adaptor proteins MAVS and STING transduce signals from the cytosolic nucleic acid sensors RIG-I and cGAS, respectively, to induce type I interferons (IFNs) and other antiviral molecules. Here we show that MAVS and STING harbor two conserved serine and threonine clusters that are phosphorylated by the kinases IKK and/or TBK1 in response to stimulation. Phosphorylated MAVS and STING then bind to a positively charged surface of interferon regulatory factor 3 (IRF3) and thereby recruit IRF3 for its phosphorylation and activation by TBK1. We further show that TRIF, an adaptor protein in Toll-like receptor signaling, activates IRF3 through a similar phosphorylation-dependent mechanism. These results reveal that phosphorylation of innate adaptor proteins is an essential and conserved mechanism that selectively recruits IRF3 to activate the type I IFN pathway.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25636800     DOI: 10.1126/science.aaa2630

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  561 in total

Review 1.  Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer.

Authors:  Leticia Corrales; Thomas F Gajewski
Journal:  Clin Cancer Res       Date:  2015-09-15       Impact factor: 12.531

Review 2.  Translating nucleic acid-sensing pathways into therapies.

Authors:  Tobias Junt; Winfried Barchet
Journal:  Nat Rev Immunol       Date:  2015-08-21       Impact factor: 53.106

Review 3.  Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.

Authors:  Nadia R Roan; Martin R Jakobsen
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

4.  A PTENtial cause for the selectivity of oncolytic viruses?

Authors:  Brian R Champion; Kerry Fisher; Len Seymour
Journal:  Nat Immunol       Date:  2016-03       Impact factor: 25.606

5.  BioID screening of biotinylation sites using the avidin-like protein Tamavidin 2-REV identifies global interactors of stimulator of interferon genes (STING).

Authors:  Kou Motani; Hidetaka Kosako
Journal:  J Biol Chem       Date:  2020-06-17       Impact factor: 5.157

6.  Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1.

Authors:  Zachary M Parker; Aisling A Murphy; David A Leib
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

Review 7.  DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer.

Authors:  Søren R Paludan; Line S Reinert; Veit Hornung
Journal:  Nat Rev Immunol       Date:  2019-03       Impact factor: 53.106

8.  The small GTPase RAB1B promotes antiviral innate immunity by interacting with TNF receptor-associated factor 3 (TRAF3).

Authors:  Dia C Beachboard; Moonhee Park; Madhuvanthi Vijayan; Daltry L Snider; Dillon J Fernando; Graham D Williams; Sydney Stanley; Michael J McFadden; Stacy M Horner
Journal:  J Biol Chem       Date:  2019-08-02       Impact factor: 5.157

9.  STING Promotes Homeostasis via Regulation of Cell Proliferation and Chromosomal Stability.

Authors:  Diana Rose E Ranoa; Ryan C Widau; Stephen Mallon; Akash D Parekh; Claudia M Nicolae; Xiaona Huang; Michael J Bolt; Ainhoa Arina; Renate Parry; Stephen J Kron; George-Lucian Moldovan; Nikolai N Khodarev; Ralph R Weichselbaum
Journal:  Cancer Res       Date:  2018-11-27       Impact factor: 12.701

10.  Identification of Uncharacterized Components of Prokaryotic Immune Systems and Their Diverse Eukaryotic Reformulations.

Authors:  A Maxwell Burroughs; L Aravind
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.